SCHEMBL16627119

SCHEMBL16627119

Cc1ccccc1N(c1ccc2ccccc2c1)c1ccc2ccccc2c1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP2A6 P11509 8/20 0.43
TDP1 Q9NUW8 1/20 0.43
HTT P42858 1/20 0.41
NPSR1 Q6W5P4 1/20 0.41
L3MBTL1 Q9Y468 1/20 0.41
CYP1A2 P05177 6/20 0.38
SIGMAR1 Q99720 1/20 0.36
NPC1 O15118 2/20 0.36
RAB9A P51151 2/20 0.36
INSR P06213 1/20 0.36
IGF1R P08069 1/20 0.36
CA1 P00915 2/20 0.35
CA2 P00918 2/20 0.35
ALDH1A1 P00352 3/20 0.35
HSD17B10 Q99714 2/20 0.35
HPGD P15428 1/20 0.35
MEN1 O00255 1/20 0.35
HSP90AA1 P07900 1/20 0.35
KMT2A Q03164 1/20 0.35
CYP3A4 P08684 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16627121 0.95 CYP2A6 (0.39) CYP2A6TDP1HTTNPSR1L3MBTL1
SCHEMBL9351033 0.92 CYP2A6 (0.37) CYP2A6TDP1HTTNPSR1L3MBTL1
SCHEMBL17734599 0.92 CYP2A6 (0.37) CYP2A6TDP1HTTNPSR1L3MBTL1
SCHEMBL17734758 0.92 CYP2A6 (0.37) CYP2A6TDP1HTTNPSR1L3MBTL1
SCHEMBL24475326 0.88 CYP1A2 (0.38) CYP2A6TDP1HTTNPSR1L3MBTL1
SCHEMBL17734689 0.88 CYP2A6 (0.37) CYP2A6TDP1HTTNPSR1L3MBTL1
SCHEMBL5071868 0.87 CYP1A2 (0.42) CYP2A6TDP1HTTNPSR1L3MBTL1
SCHEMBL18134973 0.87 CYP2A6 (0.44) CYP2A6TDP1HTTNPSR1L3MBTL1
SCHEMBL17734491 0.87 HTT (0.36) CYP2A6TDP1HTTNPSR1L3MBTL1
SCHEMBL13372119 0.85 RELA (0.46) TDP1HTTNPSR1L3MBTL1NPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 19 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3109914-B1 CHARGE-TRANSPORTING VARNISH NISSAN CHEMICAL CORP (JP) 2021-04-28 EP disclosed
EP-3053910-B1 ANILINE DERIVATIVES AND USES THEREOF NISSAN CHEMICAL CORP (JP) 2021-04-28 EP disclosed
US-10700283-B2 Aniline derivatives and uses thereof NISSAN CHEMICAL INDUSTRIES, LTD. (JP) 2020-06-30 US disclosed
EP-3608983-A1 CHARGE-TRANSPORTING VARNISH Nissan Chemical Corporation (JP) 2020-02-12 EP disclosed
US-20200032140-A1 CHARGE-TRANSPORTING VARNISH NISSAN CHEMICAL CORPORATION (JP) 2020-01-30 US disclosed
EP-3425689-B1 CHARGE-TRANSPORTING VARNISH NISSAN CHEMICAL CORP (JP) 2019-10-23 EP disclosed
US-10301484-B2 Varnish for formation of charge-transporting thin film NISSAN CHEMICAL INDUSTRIES, LTD. (JP) 2019-05-28 US disclosed
EP-3425689-A1 CHARGE-TRANSPORTING VARNISH Nissan Chemical Corporation (JP) 2019-01-09 EP disclosed
EP-3270433-A1 COMPOSITION FOR FORMING CHARGE-TRANSPORTING THIN FILM FOR ORGANIC ELECTROLUMINESCENT ELEMENTS, CHARGE-TRANSPORTING THIN FILM FOR ORGANIC ELECTROLUMINESCENT ELEMENTS, AND ORGANIC ELECTROLUMINESCENT ELEMENT Nissan Chemical Industries, Ltd. (JP) 2018-01-17 EP disclosed
US-20180002539-A1 VARNISH FOR FORMATION OF CHARGE-TRANSPORTING THIN FILM NISSAN CHEMICAL INDUSTRIES, LTD. (JP) 2018-01-04 US disclosed
EP-3252840-A1 VARNISH FOR FORMATION OF CHARGE-TRANSPORTING THIN FILM Nissan Chemical Industries, Ltd. (JP) 2017-12-06 EP disclosed
US-20170213986-A1 CHARGE TRANSPORT MATERIAL NISSAN CHEMICAL INDUSTRIES, LTD. (JP) 2017-07-27 US disclosed
US-20170213986-A1 CHARGE TRANSPORT MATERIAL NISSAN CHEMICAL INDUSTRIES, LTD. (JP) 2017-07-27 US disclosed
EP-3174115-A1 CHARGE TRANSPORT MATERIAL Nissan Chemical Industries, Ltd. (JP) 2017-05-31 EP disclosed
US-20160301011-A1 ANILINE DERIVATIVES AND USES THEREOF NISSAN CHEMICAL INDUSTRIES, LTD. (JP) 2016-10-13 US disclosed
US-20160301011-A1 ANILINE DERIVATIVES AND USES THEREOF NISSAN CHEMICAL INDUSTRIES, LTD. (JP) 2016-10-13 US disclosed
WO-2016117521-A1 VARNISH FOR FORMATION OF CHARGE-TRANSPORTING THIN FILM 日産化学工業株式会社 2016-07-28 WO disclosed
WO-2016013533-A1 CHARGE TRANSPORT MATERIAL 日産化学工業株式会社 2016-01-28 WO disclosed
WO-2015050253-A1 ANILINE DERIVATIVES AND USES THEREOF 日産化学工業株式会社 2015-04-09 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20160301011-A1 ANILINE DERIVATIVES AND USES THEREOF SLC18A1, SLC18A2, SLC43A1 CYP2A6 1621/4885TDP1 1871/4885HTT 2225/4885
US-10700283-B2 Aniline derivatives and uses thereof SLC18A1, SLC18A2, SLC43A1 CYP2A6 1621/4885TDP1 1871/4885HTT 2225/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.